N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
19
ORGANISATION AFRICAINE DE LA PROPRIETE INTELLECTUELLE
51 8 Inter. CI. A61K 31/437 (2018.01) 11 A61K 31/496 (2018.01)
N° 18380 A61K 31/5377 (2018.01) A61P 35/02 (2018.01)
FASCICULE DE BREVET D'INVENTION
21 Numéro de dépôt : 1201700302 73 Titulaire(s): PCT/US2016/015727
GILEAD SCIENCES, INC.,
333 Lakeside Drive, 22 Date de dépôt : 29/01/2016 FOSTER CITY,
CA 94404 (US)
30 Priorité(s):
Inventeur(s): US n° 62/111,604 du 03/02/2015 72
DI PAOLO Julie A. (US) TUMAS Daniel B. (US) JONES Randall Mark (US)
24 Délivré le : 31/08/2018
74 Mandataire: GAD CONSULTANTS SCP,
P.O. Box 13448, YAOUNDE (CM). 45 Publié le : 02.11.2018
54 Titre: Combination therapies for treating cancers.
57 Abrég é :
Provided herein are methods that relate to a therapeutic strategy for treatment of cancer, including hematological malignancies. In particular, the methods include administration entospletinib and a Bcl-2 inhibitor, such as venetoclax, navitoclax, and ABT-737.
O.A.P.I. – B.P. 887, YAOUNDE (Cameroun) – Tel. (237) 222 20 57 00 – Site web: http:/www.oapi.int – Email: [email protected]